Forsythe Elizabeth, Sparks Kathryn, Best Sunayna, Borrows Sarah, Hoskins Bethan, Sabir Ataf, Barrett Timothy, Williams Denise, Mohammed Shehla, Goldsmith David, Milford David V, Bockenhauer Detlef, Foggensteiner Lukas, Beales Philip L
Genetics and Genomic Medicine Program, University College London Great Ormond Street Institute of Child Health,
National Bardet-Biedl Syndrome Service, Department of Clinical Genetics, Great Ormond Street Hospital, London, United Kingdom.
J Am Soc Nephrol. 2017 Mar;28(3):963-970. doi: 10.1681/ASN.2015091029. Epub 2016 Sep 22.
Bardet-Biedl syndrome is a rare autosomal recessive, multisystem disease characterized by retinal dystrophy, renal malformation, obesity, intellectual disability, polydactyly, and hypogonadism. Nineteen disease-causing genes () have been identified, of which mutations in are most common in North America and Europe. A hallmark of the disease, renal malformation is heterogeneous and is a cause of morbidity and mortality through the development of CKD. We studied the prevalence and severity of CKD in 350 patients with Bardet-Biedl syndrome-related renal disease attending the United Kingdom national Bardet-Biedl syndrome clinics to further elucidate the phenotype and identify risk indicators of CKD. Overall, 31% of children and 42% of adults had CKD; 6% of children and 8% of adults had stage 4-5 CKD. In children, renal disease was often detected within the first year of life. Analysis of the most commonly mutated disease-associated genes revealed that, compared with two truncating mutations, two missense mutations associated with less severe CKD in adults. Moreover, compared with mutations in , mutations in associated with less severe CKD or lack of CKD in adults. Finally, 51% of patients with available ultrasounds had structural renal abnormalities, and 35% of adults were hypertensive. The presence of structural abnormalities or antihypertensive medication also correlated statistically with stage 3b-5 CKD. This study describes the largest reported cohort of patients with renal disease in Bardet-Biedl syndrome and identifies risk factors to be considered in genetic counseling.
巴德-比埃尔综合征是一种罕见的常染色体隐性多系统疾病,其特征为视网膜营养不良、肾脏畸形、肥胖、智力残疾、多指(趾)畸形和性腺功能减退。已鉴定出19个致病基因,其中在北美和欧洲,[具体基因名称]的突变最为常见。肾脏畸形是该疾病的一个标志,具有异质性,是慢性肾脏病(CKD)发展导致发病和死亡的原因。我们研究了350例在英国国家巴德-比埃尔综合征诊所就诊的与巴德-比埃尔综合征相关肾脏疾病患者的CKD患病率和严重程度,以进一步阐明其表型并确定CKD的风险指标。总体而言,31%的儿童和42%的成人患有CKD;6%的儿童和8%的成人患有4 - 5期CKD。在儿童中,肾脏疾病常在出生后第一年内被检测到。对最常发生突变的疾病相关基因的分析显示,与两个截短突变相比,两个错义突变在成人中与较轻的CKD相关。此外,与[具体基因名称]的突变相比,[另一个具体基因名称]的突变在成人中与较轻的CKD或无CKD相关。最后,51%接受超声检查的患者存在肾脏结构异常,35%的成人患有高血压。结构异常或使用抗高血压药物的情况在统计学上也与3b - 5期CKD相关。本研究描述了已报道的最大规模的巴德-比埃尔综合征肾脏疾病患者队列,并确定了遗传咨询中应考虑的风险因素。